Norgesic

{{Short description|Muscle relaxant}}

{{Drugbox

| verifiedrevid = 413073463

| type = combo

| component1 = Aspirin

| class1 =

| component2 = Caffeine

| class2 =

| tradename =

| Drugs.com = {{drugs.com|CONS|norgesic}}

| MedlinePlus = a682162

| routes_of_administration = Oral

| CAS_number = 509146-28-5

}}

Norgesic is the brand name of a muscle relaxant produced by Galt Pharmaceuticals{{Cite web |title=DailyMed - NORGESIC- orphenadrine citrate, aspirin and caffeine tablet |url=https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=be2761bc-e537-4039-846a-2ffa3d8b2afc |access-date=2025-06-11 |website=dailymed.nlm.nih.gov}}. The generic is a combination of 385 mg of aspirin, 25 mg of orphenadrine citrate{{cite web |title=Norgesic |url=https://www.drugs.com/pro/norgesic.html |work=drugs.com}} and 30 mg of caffeine.{{Cite book | title = Back Pain: A Guide for the Primary Care Physician | vauthors = Haig AJ | publisher = Versa Press | year = 2005 | page = [https://books.google.com/books?id=hYdK_8YDcREC&pg=PA151 151] | isbn = 1-930513-59-3 }}

It was discontinued in the United States in October 2015

{{cite web

|url=https://www.gpo.gov/fdsys/pkg/FR-2015-10-30/html/2015-27740.htm

|title=Determination That TENSILON and TENSILON Preservative Free (Edrophonium Chloride) Injectable and Other Drug Products Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness

|date = 2015-10-30

|archive-url = https://web.archive.org/web/20170826063443/https://www.gpo.gov/fdsys/pkg/FR-2015-10-30/html/2015-27740.html

|archive-date = 2017-08-26

|publisher=Food and Drug Administration, Federal Register Volume 80, # 210

|access-date=2017-08-26}} but was returned to the United States market in 2022 and is still available in Scandinavia, Austria, Greece, Thailand, Australia and Hong Kong.{{Citation needed|date=September 2016}}

In some countries Norgesic has a different pharmaceutical combination. For example in Greece the combination of 450 mg of aspirin, 35 mg of orphenadrine citrate is common.